These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8428082)

  • 1. Proton relaxation enhancement.
    Wood ML; Hardy PA
    J Magn Reson Imaging; 1993; 3(1):149-56. PubMed ID: 8428082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic principles of MR contrast.
    Nelson KL; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.
    Tanimoto A; Yuasa Y; Stark DD
    Invest Radiol; 1994 Jun; 29 Suppl 2():S78-80. PubMed ID: 7523329
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.
    Tanimoto A; Pouliquen D; Kreft BP; Stark DD
    J Magn Reson Imaging; 1994; 4(5):653-7. PubMed ID: 7526912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical models of transverse relaxation for spherical magnetic perturbers.
    Yung KT
    Magn Reson Imaging; 2003 Jun; 21(5):451-63. PubMed ID: 12878254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The magnetic properties of some materials affecting MR images.
    Josephson L; Bigler J; White D
    Magn Reson Med; 1991 Dec; 22(2):204-8; discussion 213-5. PubMed ID: 1812347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
    Weisskoff RM; Kiihne S
    Magn Reson Med; 1992 Apr; 24(2):375-83. PubMed ID: 1569876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles.
    Koenig SH; Kellar KE
    Magn Reson Med; 1995 Aug; 34(2):227-33. PubMed ID: 7476082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory of proton relaxation in solutions of magnetic nanoparticles, including the superparamagnetic size range.
    Koenig SH; Kellar KE
    Acad Radiol; 1996 Aug; 3 Suppl 2():S273-6. PubMed ID: 8796579
    [No Abstract]   [Full Text] [Related]  

  • 13. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite.
    Gillis P; Koenig SH
    Magn Reson Med; 1987 Oct; 5(4):323-45. PubMed ID: 2824967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic in vivo video microscopic study for evaluating experimental and approved magnetic resonance contrast agents.
    Kruskal JB; Lunderquist A; Clouse ME
    Invest Radiol; 1994 Jun; 29 Suppl 2():S83-6. PubMed ID: 7928279
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents.
    Gossuin Y; Roch A; Muller RN; Gillis P
    J Magn Reson; 2002; 158(1-2):36-42. PubMed ID: 12419669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
    Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
    Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport.
    Bauer WR; Schulten K
    Magn Reson Med; 1992 Jul; 26(1):16-39. PubMed ID: 1625562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of AMI-227 as an oral MR contrast agent.
    Rogers J; Lewis J; Josephson L
    Magn Reson Imaging; 1994; 12(4):631-9. PubMed ID: 8057768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR contrast due to intravascular magnetic susceptibility perturbations.
    Boxerman JL; Hamberg LM; Rosen BR; Weisskoff RM
    Magn Reson Med; 1995 Oct; 34(4):555-66. PubMed ID: 8524024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
    Kuwatsuru R; Brasch RC; Mühler A; Mathur A; Vexler VS; Rosenau W; Mintorovitch J; Berthezene Y; Cohen F; Shames DM
    Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.